Abstract
Aim: The CD133 antigen has been identified as a putative stem cell marker in colorectal cancer tissues. The aim of this study was to investigate the cell cycle state of CD133+ and CD133- cells, isolated from primary human colorectal tumors. Materials and Methods: After mechanical and enzymatic dissociation of the tumor samples, CD133+ and CD133 - subsets were identified and separated by magnetic cell sorting. Flow cytometric analysis was performed to compare the cell cycle of both CD133+ and CD133- cells isolated from primary and liver metastatic cancer cells. Results: The results indicated that CD133+ cells isolated from both primary and liver metastatic colorectal cancers were found in higher percentage in the G0/G1 phases. However, the CD133- cells isolated from primary colorectal cancers were predominantly found in the S and G2/M phases. Surprisingly, the CD133- cells isolated from liver metastatic colorectal cancers were mostly found in the G0/G1 phase. Conclusion: The present study provides evidence that CD133+ cells are in a quiescent state in colorectal cancer, representing a mechanism that would at least partially explain chemotherapy resistance and tumor recurrence in post-Therapy patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 399-403 |
| Number of pages | 5 |
| Journal | Journal of Cancer Research and Therapeutics |
| Volume | 8 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jul 2012 |
| Externally published | Yes |
Keywords
- CD133
- Cancer stem cells
- Cell cycle
- Colorectal cancer
ASJC Scopus subject areas
- Oncology
- Radiology Nuclear Medicine and imaging
Fingerprint
Dive into the research topics of 'Cell cycle analysis of the CD133+ and CD133- cells isolated from human colorectal cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS